Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway

Midori Kjellin, Hege Kileng, Dario Akaberi, Navaneethan Palanisamy, Ann‐Sofi Duberg, Astrid Danielsson, Magnhild Gangsøy Kristiansen, Johan Nöjd, Soo Aleman, Tore Jarl Gutteberg,

Scandinavian Journal of Gastroenterology · 2019 · 16 citations · 22 references

DOIFull text

Open access

Concepts

Abstract

The results from this real-life study are in accordance with the findings of the randomised controlled trials in 2015 and the EASL-guidelines of 2016, thus, baseline Y93H impacts on DCV and VEL treatment outcome.

References

22